Healthcare spending growth projected to outpace GDP to 2032
Jun 13, 2024
National health expenditures are projected to have increased 7.5% in 2023, when the COVID-19 public health emergency ended.
Lifestyle intervention can improve cognition, function in early Alzheimer’s disease
Jun 13, 2024
A significant correlation was seen between lifestyle and both cognitive function and Aβ42/40 ratio.
Residual risk seen for death, postacute sequelae in third year after COVID-19 hospitalization
Jun 13, 2024
The risk for death remains significantly elevated in the third year, as is risk for incident postacute sequelae of COVID-19.
Systemic side effects of COVID-19 vaccine tied to greater nAB response
Jun 11, 2024
Each 1-degree Celsius increase in skin temperature after a dose was linked to a 1.8- and 3.1-fold higher neutralizing antibody response one and six months later.
Heat exposure increases myocardial blood flow
Jun 11, 2024
There was an approximately twofold increase seen from preexposure values with core temperature increase of 1.5 degrees Celsius.
Melatonin use linked to reduced risk for development, progression of AMD
Jun 11, 2024
Melatonin use was linked to a reduced risk for developing age-related macular degeneration and for progression from nonexudative to exudative AMD.
The 5-Cog paradigm improves diagnosis, management of dementia
Jun 11, 2024
A threefold improvement was seen in dementia care actions with the 5-Cog paradigm, a culturally adept cognitive detection tool.
Expert panel develops new definition of long COVID
Jun 11, 2024
A new proposed definition for Long COVID could help patients get the help they need, a new report from the National Academies of Sciences, Engineering and Medicine says.
FDA advisers support new Alzheimer’s drug
Jun 11, 2024
A US Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and...
Nirmatrelvir-ritonavir no aid for long COVID symptoms
Jun 10, 2024
The findings based on symptoms at 10 weeks following 15-day course in vaccinated cohort.